Eastman Chemical (EMN) Reports In-Line Q4 EPS; offers guidance

Eastman Chemical (NYSE: EMN) reported Q4 EPS of $0.75, in-line with the analyst estimate of $0.75. Revenue for the quarter came in at $1.97 billion versus the consensus estimate of $2.03 billion.

GUIDANCE:

Eastman Chemical sees Q1 2026 EPS of $1.00-$1.20, versus the consensus of $1.28.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.

You May Also Be Interested In

• Jefferies Financial Group (JEF) Tops Q3 EPS by 8c
• Trump says no sanctions relief was offered to Iran
• AstraZeneca invests $2B in Summit Therapeutics preferred shares